These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32949121)

  • 1. Prognostic Value of SLC4A4 and its Correlation with Immune Infiltration in Colon Adenocarcinoma.
    Chen X; Chen J; Feng Y; Guan W
    Med Sci Monit; 2020 Sep; 26():e925016. PubMed ID: 32949121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
    Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
    Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profile reveals immune-associated markers of lymphatic invasion in human colon adenocarcinoma.
    Shi J; Jiang D; Yang S; Sun Y; Wang J; Zhang X; Liu Y; Lu Y; Yang K
    Int Immunopharmacol; 2020 Jun; 83():106402. PubMed ID: 32200154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
    Gao X; Yang J
    DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 7. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
    Jiang C; Liu Y; Wen S; Xu C; Gu L
    Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics Analysis of
    Wu L; Tian X; Du H; Liu X; Wu H
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression mode and prognostic value of FXYD family members in colon cancer.
    Jin M; Zhang H; Yang J; Zheng Z; Liu K
    Aging (Albany NY); 2021 Jul; 13(14):18404-18422. PubMed ID: 34270462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the Prognostic Value and Clinical Significance of Interferon Regulatory Factors (IRFs) in Colon Adenocarcinoma.
    Yuemaier M; Zhou Z; Zhou Y; Wu C; Li F; Liang X; Kang H; Shen D; Gao F; Lin J
    Med Sci Monit; 2020 Nov; 26():e927073. PubMed ID: 33161410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 65‑gene signature for prognostic prediction in colon adenocarcinoma.
    Jiang H; Du J; Gu J; Jin L; Pu Y; Fei B
    Int J Mol Med; 2018 Apr; 41(4):2021-2027. PubMed ID: 29393333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNA-sequencing.
    Liu J; Liu F; Li X; Song X; Zhou L; Jie J
    Tumour Biol; 2017 Jul; 39(7):1010428317714899. PubMed ID: 28714374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC4A4 moulds the inflammatory tumor microenvironment and predicts therapeutic expectations in colorectal cancer.
    Xiang D; Li H; Pan J; Chen Y
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38310390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of IAP family proteins in colon cancers from patients with different age groups.
    Endo T; Abe S; Seidlar HB; Nagaoka S; Takemura T; Utsuyama M; Kitagawa M; Hirokawa K
    Cancer Immunol Immunother; 2004 Sep; 53(9):770-6. PubMed ID: 15138717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma.
    Meng C; Zhang Y; Jiang D; Wang J
    World J Surg Oncol; 2022 Mar; 20(1):89. PubMed ID: 35307012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Molecular Targets for Predicting Colon Adenocarcinoma.
    Wang Y; Zhang J; Li L; Xu X; Zhang Y; Teng Z; Wu F
    Med Sci Monit; 2016 Feb; 22():460-8. PubMed ID: 26868022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Na(+)/HCO3(-) Co-Transporter SLC4A4 Plays a Role in Growth and Migration of Colon and Breast Cancer Cells.
    Parks SK; Pouyssegur J
    J Cell Physiol; 2015 Aug; 230(8):1954-63. PubMed ID: 25612232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SSR4 as a prognostic biomarker and related with immune infiltration cells in colon adenocarcinoma.
    He W; Wang B; He J; Zhao Y; Zhao W
    Expert Rev Mol Diagn; 2022 Feb; 22(2):223-231. PubMed ID: 34904499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.